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Abstract
Context—The childhood precursors of adult bipolar disorder (BP) are still a matter of 
controversy.
Objective—To report the lifetime prevalence and early clinical predictors of psychiatric 
disorders in offspring from families of probands with DSM-IV BP compared with offspring of 
control subjects.
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Design—A longitudinal, prospective study of individuals at risk for BP and related disorders. We 
report initial (cross-sectional and retrospective) diagnostic and clinical characteristics following 
best-estimate procedures.
Setting—Assessment was performed at 4 university medical centers in the United States between 
June 1, 2006, and September 30, 2009.
Participants—Offspring aged 12 to 21 years in families with a proband with BP (n=141, 
designated as cases) and similarly aged offspring of control parents (n=91).
Main Outcome Measure—Lifetime DSM-IV diagnosis of a major affective disorder (BP type I; 
schizoaffective disorder, bipolar type; BP type II; or major depression).
Results—At a mean age of 17 years, cases showed a 23.4% lifetime prevalence of major 
affective disorders compared with 4.4% in controls (P=.002, adjusting for age, sex, ethnicity, and 
correlation between siblings). The prevalence of BP in cases was 8.5% vs 0% in controls (adjusted 
P=.007). No significant difference was seen in the prevalence of other affective, anxiety, 
disruptive behavior, or substance use disorders. Among case subjects manifesting major affective 
disorders (n=33), there was an increased risk of anxiety and externalizing disorders compared with 
cases without mood disorder. In cases but not controls, a childhood diagnosis of an anxiety 
disorder (relative risk=2.6; 95% CI, 1.1–6.3; P=.04) or an externalizing disorder (3.6; 1.4–9.0; P=.
007) was predictive of later onset of major affective disorders.
Conclusions—Childhood anxiety and externalizing diagnoses predict major affective illness in 
adolescent offspring in families with probands with BP.
Bipolar Disorder (BP) is a highly heritable disorder with up to 85% of variance in risk 
determined by genetic factors.1,2 Family history remains the strongest predictive factor for 
development of the disorder. Studies3–6 of late adolescent and young adult offspring of 
parents with BP clearly show an increased onset of major affective disorders, including 
recurrent major depression, BP type I (BPI), and BPII. Adolescent offspring in families of 
probands with BP (the initially identified subject in a family/genetic study) are at 8- to 10-
fold increased lifetime risk for BP and at 3-fold increased lifetime risk for major affective 
disorders in general.1
Studies of offspring of probands with BP have typically found a general increase in 
psychiatric diagnoses in childhood.7–14 It is unclear to what extent this increase in diagnoses 
is an indicator of risk of later mood disorder and to what extent it reflects the stress of living 
with an affected parent or other familial factors.
The extant literature points to at least 3 common, clinically significant phenotypes related to 
BP. Attention deficit and disruptive behavior disorders are more frequently diagnosed in 
adolescents with bipolar spectrum disorders6,11,12,15–18 and are typically diagnosed in 
advance of BP. In adolescence, there is an increase in the prevalence of substance use 
disorders in individuals with BP, and such disorders may be associated with early age at 
onset of mood disorder.19–21 There is evidence21 that individuals with BP and substance use 
disorders show an increased prevalence of BP in first-degree relatives compared with other 
individuals with BP.
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There also seems to be an increased rate of anxiety disorders in subjects with BP. A 
common genetic etiology has been proposed for BP and comorbid anxiety disorders.22–24 
Severity of major affective illness is related to the presence of comorbid anxiety in 
adolescents and adults, and children with anxiety disorders are significantly more likely to 
develop BP13,24–26 than are children without anxiety disorders. Anxiety disorders may be 
increased in offspring of subjects with BP.11–13 Finally, mood disorder spectrum conditions 
are increased in families with a proband with BP, and BP not otherwise specified (BPNOS) 
may predict BPI or BPII.13
We may think of these different syndromes as (1) externalizing (including substance use 
disorders and disruptive behavior disorders), (2) internalizing, and (3) pure affective. It is 
unclear whether they should be conceptualized as a latent classification of patients or as 
vulnerability factors that affect all patients with BP through their life course to varying 
degrees. These syndromes may affect the onset and course of BP and related conditions and 
may offer different opportunities for preventive intervention. In the present study, we 
attempted to evaluate these 3 psychiatric phenotypes using diagnostic assessment and 
specific symptom ratings in at-risk subjects.
Studies involving high-risk subgroups have the distinct advantage of engaging study 
subjects prior to the onset of the disorder; they offer the ability to prospectively detail the 
emerging psychopathologic condition and provide for comparison between at-risk offspring 
who become affected and those who do not become affected.19,24 Longitudinal studies that 
ascertain at-risk participants and monitor them prospectively are the most effective approach 
for identifying specific etiologic factors.8,9,26–28 The present study uses best-estimate 
diagnoses for childhood disorders as well as adolescent/young adult mood disorder; we also 
investigated the time course of disorder onset.
We identified at-risk offspring from cohorts specifically selected for genetic study. Cases 
and controls were compared for lifetime diagnoses; we then characterized subtypes of case 
offspring at increased risk for major affective disorders. We hypothesized that early 
internalizing disorders and externalizing disorders (or both) would predict the onset of major 
affective disorders in families affected by bipolar illness. The advantage of the study design 
is that it identifies subphenotypes and allows incorporation of cohort-specific genetic risk 
markers as the study progresses.
METHODS
SUBJECTS
All the clinical procedures were approved by institutional review boards at the 4 subject 
collection sites: Indiana University School of Medicine, Indianapolis (coordinating site); 
University of Michigan, Ann Arbor; The Johns Hopkins University School of Medicine, 
Baltimore, Maryland; and Washington University at St Louis, St Louis, Missouri. Informed 
consent (or assent with parental consent for subjects <18 years old) was obtained after a 
thorough explanation of the study. “Case” offspring (the term as used herein does not 
connote illness but rather “at-risk” status) were ascertained through probands with BP, 
available from the National Institute of Mental Health Genetics Initiative bipolar sample 
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(http://zork.wustl.edu)29 or similar genetic studies. To our knowledge, all the probands were 
in treatment at the time of ascertainment (approximately 95% in outpatient treatment and 5% 
in inpatient treatment).
Probands were characterized using the Diagnostic Interview for Genetic Studies29 and the 
Family Instrument for Genetic Studies30 and had a lifetime DSM-IV diagnosis of BPI 
(n=126 offspring of 78 probands), BPII with recurrent major depression (n=10 offspring of 6 
probands), or schizoaffective disorder, bipolar type (n=5 offspring of 4 probands). For 114 
offspring, the proband was a parent, for 13 an older sibling, for 13 an uncle or aunt, and for 
1 grandparent. Second-degree relatives were included only when the family was multiplex 
(at least a proband with BPI and a first-degree relative of the proband with BPI/
schizoaffective disorder, bipolar type); multiplex families are associated with a generally 
higher risk of illness in relatives.31 The high-risk sample comprised 91 families, 55 with a 
single offspring, 26 with 2 offspring, 8 with 3 offspring, and 1 each with 4 and 6 offspring. 
Of the 141 adolescent cases, 85 were from multiplex BP families (41 confirmed by family 
study and 44 by the Family Instrument for Genetic Studies), 51 were from simplex families 
(proband with BP, no first-degree relative with BP), and 5 were from BP families with an 
unknown extended family history.
Control parents were recruited through general medicine clinics, motor vehicle records, and 
campus advertising. Exclusion criteria for control parents included BPI, BPII, recurrent 
major depression, schizoaffective disorder, or schizophrenia in either parent; we also 
excluded parents with a first-degree relative with a psychiatric hospitalization. The 91 
controls are from 58 families: 33 with 1 adolescent offspring, 18 with 2, 6 with 3, and 1 with 
4. Forty-eight percent of cases were male compared with 53% of controls (P=.59). Eighty-
nine percent of cases were European American vs 66% of controls (P<.001). Ethnicity was 
assessed by self-report using the 7 US census categories. The mean (SD) age of cases was 
16.7 (3.3) years and of controls was 16.0 (3.1) years (P=.11). Subsequent analyses adjusted 
for these variables. The occupation of the head of the household was used as a proxy for 
socioeconomic status (no significant difference between groups). These data are summarized 
in Table 1.
Data were collected between June 1, 2006, and September 30, 2009. In families of cases and 
controls, all offspring aged 12 to 21 years were invited to participate by being interviewed 
(using the Kiddie Schedule for Affective Disorders [K-SADS]) and providing a blood 
specimen for DNA analysis. At least 1 parent had to be living and available for interview; 
parents were interviewed about themselves (using the Diagnostic Interview for Genetic 
Studies), about their spouse and other relatives (using the Family Instrument for Genetic 
Studies), and about all their offspring (using the K-SADS, Parent Version [K-SADS-P]).32 
Fifteen offspring in the age range in the case families did not participate in the study; family 
history information indicates that 1 of the nonparticipants had autism. Four offspring in the 
age range in the control families did not participate; family history information indicates that 
1 had cerebral palsy. Probands with substantial cognitive impairment were not included. In 
offspring, IQ was not formally tested, but each subject was required to be able to complete 
the interview and the individual questionnaires as part of the study protocol. One control 
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participant was diagnosed as having a learning disability and possible intellectual disability 
during the best-estimate process.
PROCEDURE
The initial task was to establish an assessment procedure for Axis I disorders in children and 
adolescents. The versions of the K-SADS we reviewed had 2 major limitations: (1) they did 
not define specific episodes in time and duration before assessing symptoms and (2) they did 
not include questions targeting each DSM-IV criterion item for affective disorders. We 
adapted questions and interviewer instructions from the Diagnostic Interview for Genetic 
Studies to address these issues. Additional questions from the Washington University 
version of the K-SADS33 were incorporated to provide phenomenologic detail. We 
developed anchor points for each symptom. We also incorporated screening for organic 
affective syndromes and psychosis. We then piloted the resulting interview in adolescent 
subjects (K-SADS) and their parents (K-SADS-P) at each of the collaborative sites. The 
interview was prepared in computer-scorable form, which can also be used for data entry. 
The K-SADS-BP is now available at http://www.bipolargenes.org/hrdownloads.html and is 
fully computerized. Diagnoses are not algorithmic but are generated by clinical consensus, 
as noted later herein. Interviewers were extensively trained by the principal investigators and 
coordinators at each site after a weeklong common training at the Indiana University 
coordinating site. At each site, the interviewers or clinical coordinators had an extensive 
clinical background. Interviews were performed either in person (35.2%) or by telephone 
(64.8%). The reliability of telephone interview for such purposes has been documented.34 
Interviewers were not blind to subject status, in keeping with previous family study 
practices.35 Interviewers were blind to the specific hypotheses of the study.
Diagnoses and age at onset determinations were made on the basis of consensus between 2 
clinicians (ie, psychiatrists with child specialty training, clinical psychologists, or clinical 
social workers), including information from direct interview (retrospective data), medical 
records (cross-sectional data), and parent interview (retrospective data). Best-estimate 
clinicians were blinded to the case-control status of the participant. Lifetime diagnoses were 
assigned according to DSM-IV criteria, including BPNOS, which was generally diagnosed 
only if the participant approached the criteria for BPII but had 1 fewer symptom in the 
hypomanic and depressive categories. Diagnoses of mania were made by consensus, with 
strict adherence to DSM-IV criteria. The κ value for interrater reliability for a major affective 
disorder diagnosis was 0.82 and for other disorder categories ranged from 0.70 to 0.85. A 
subgroup of 30 subjects with an interview diagnosis of major affective disorder was 
examined as an assessment of internal validity: 25 of these subjects also had major affective 
disorders on best estimate (83%); 21 of 30 (70%) showed agreement on disorder subtype. 
The best-estimate process also included consensus ratings of lifetime symptom severity (a 
combination of frequency and intensity of symptoms) in the categories of mood, anxiety, 
and behavior using a 7-point scale. Weighted κ values were 0.77 for ratings of lifetime 
mood symptom severity, 0.70 for behavioral symptoms, and 0.67 for anxiety symptoms.
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STATISTICAL ANALYSES
Demographic and clinical characteristics were compared between cases (n=141) and 
controls (n=91) using the Fisher exact test, the 2-sided t test for quantitative data, or the 
Wilcoxon test for ordinal data. A logistic regression model, using generalized estimating 
equations to account for correlation between siblings, was used to compare cases and 
controls on dichotomous diagnoses while adjusting for age, sex, and ethnicity. Exact logistic 
regression was used when dichotomous diagnoses had a 0 cell count. Linear mixed models 
were used to compare cases and controls on symptom ratings. The SAS GENMOD and 
MIXED procedures were used for generalized estimating equations and linear mixed-model 
estimation, respectively.
Using age-at-onset data, we constructed Kaplan-Meier survival curves for major affective 
disorders (BPI; schizoaffective disorder, bipolar type; BPII; and major depression, recurrent 
or single episode), minor affective disorders (BPNOS, adjustment disorder with depressed 
mood, depression NOS, and dysthymia), anxiety disorders (obsessive-compulsive disorder, 
panic disorder with or without agoraphobia, simple phobia, specific phobia, separation 
anxiety disorder, generalized anxiety disorder/overanxious disorder, adjustment disorder 
with anxious mood, posttraumatic stress disorder, and other anxiety disorder), and 
externalizing disorders (attention-deficit/hyperactivity disorder, any alcohol use disorder, 
any drug use disorder, conduct disorder, oppositional defiant disorder, and other behavioral 
disorder). We report a P value for the log-rank test for the survival function. The Cox 
proportional hazards regression model, estimated using an R package routine (R Foundation 
for Statistical Computing, Vienna, Austria), was used to estimate hazard ratios for the 
survival analysis while adjusting for the effects of covariates and the familial correlation. 
The hazard ratio may be interpreted as a relative risk (RR), and we use this term in the 
analyses reported herein.
Additional analyses were performed on subgroups of cases with major affective disorders 
(n=33), minor affective disorders (n=21), and no affective disorder (n=87). Subjects with 
major affective disorders had a higher average age (18.2 years) than did those with minor 
affective disorders (16.5 years) or no affective disorder (16.2 years); no significant 
differences were noted in sex and ethnicity. We included all these characteristics (and 
sibling correlation) in the statistical models for consistency between the main analyses and 
the subgroup analyses.
RESULTS
CASE-CONTROL COMPARISONS
Table 2 provides the distribution of diagnoses in the sample: 23.4% of cases (n=33) were 
diagnosed as having major affective disorders vs 4.4% of controls (n=4) (adjusted P=.002). 
No difference in minor affective disorders (as a category or individually) was seen between 
the groups. No differences were seen in anxiety disorders, substance use disorders, attention-
deficit/hyperactivity disorder/disruptive behavior disorders, or any specific disorder in these 
diagnostic categories. No chronic psychotic disorder was seen in subjects in either group. If 
we combine subgroups of BP, 8.5% of case offspring (n=12) had BPI, BPII, or BPNOS 
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compared with 0% of control offspring (adjusted P=.007). Figure 1 shows a significant 
difference between cases and controls in the onset of major affective disorders (log-rank test 
P<.001). The adjusted RR was 5.33 (95% confidence interval [CI], 1.8–15.7; P=.002). By 
age 16 years, a mean (SE) of 25.4% (4%) of cases had a diagnosis compared with 5.7% 
(3%) of controls. No significant difference in the onset of other affective disorders, anxiety 
disorders, or behavior disorders was seen between cases and controls after adjustment (Table 
2). Sixty percent of cases had 1 or more diagnoses compared with 40% of controls (P=.09).
Best-estimate clinicians’ impressions of lifetime severity of symptoms in 3 domains are 
provided in eTable 1 (http://www.archgenpsychiatry.com). Ratings for mood symptoms 
were increased before, but not after, correction for covariates (P =.10); behavioral ratings 
were not higher in cases than controls (P =.70). Symptom ratings were intercorrelated 
(Pearson r for anxiety and mood ratings=0.60; anxiety and behavior ratings r=0.41; mood 
and behavior ratings r=0.53; all P<.001).
Table 3 compares the features of illness in cases (n=54) and controls (n=17) with major or 
minor affective disorders. Cases were more likely to have major affective diagnoses (61.1% 
vs 23.5%, P=.01), multiple mood episodes (37.0% vs 5.9%, P=.02), and impairment at 
home, at school, or with peers (44.0% vs 11.8%, P=.02). Symptom ratings for cases and 
controls with major or minor affective disorders followed the same pattern as noted 
previously herein: mood ratings were elevated in cases (P=.007) compared with controls, 
and anxiety and behavior ratings were not different in the 2 groups.
DIFFERENTIATING AFFECTED AND UNAFFECTED CASES
Within the case sample, some offspring have manifested major affective disorder and some 
have not. We divided the cases into 3 subgroups: those with major affective disorder (n=33), 
those with minor affective disorders (n=21), and those with no affective disorder (n=87). We 
used this division to check certain ascertainment variables: no difference was found in the 
distribution of cases in the 3 groups depending on whether the proband was a parent or not 
(χ2 P=.64); it also did not make a difference whether the case was interviewed by telephone 
or in person (χ2 P=.51). There is no difference in the distribution of multiplex and simplex 
families in the 3 groups (χ2 P=.74). There is also no difference when we compare offspring 
in families with a BPI proband to offspring in families with a BPII proband (Fisher exact 
test P=.90). There is also no difference when we compare offspring in families in which the 
interviewed parent was affected compared with those in which the interviewed parent was 
unaffected (Fisher exact test P=.40). Symptom ratings for cases divided by mood disorder 
outcome are presented in eTable 2 and show increased ratings in all domains for affected 
subjects.
Figure 2A shows a significant difference in the onset of anxiety disorders among the 3 
subgroups (log-rank test P<.001). Participants with major affective disorders had an adjusted 
RR of 4.0 (95% CI, 1.9–8.5; P<.001) for an anxiety diagnosis in relation to participants with 
no affective disorder. This was still true when we controlled for the presence of comorbid 
anxiety disorders in the parent/proband (RR=3.8, P<.001). Participants with minor affective 
disorders did not show an increased risk of anxiety disorder compared with participants with 
no affective diagnosis.
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Figure 2B shows a significant difference in the incidence of externalizing disorders among 
the 3 subgroups (log-rank test P<.001). The adjusted RR for externalizing disorders in 
participants with major affective disorders was 4.0 (95% CI, 1.8–8.8; P<.001) compared 
with participants with no affective disorder. This was still true when we controlled for 
comorbid externalizing disorder in the parent/proband (RR=4.2, P<.001). The RR for 
participants with minor affective disorders was 4.0 (95% CI, 1.8–9.3; P=.001) compared 
with participants with no affective disorder. When we considered attention-deficit/
hyperactivity disorder/disruptive behavioral disorders separately, the RR for participants 
with major affective disorders was 4.8 (95% CI, 1.6–14.0; adjusted P<.005) and for subjects 
with minor affective disorders was 5.5 (95% CI, 1.8–16.5; adjusted P<.002). When we 
considered substance use disorders separately, the RR for participants with major affective 
disorders was 2.1 (95% CI, 0.8–5.3; adjusted P=.13) and for participants with minor 
affective disorders was 2.7 (95% CI, 0.95–7.7; adjusted P=.06).
eTable 3 shows a division of affected cases with major affective disorder into those with 
comorbid anxiety disorders (internalizing), comorbid behavioral disorders (externalizing), 
both, or purely affective disorder. Those with both anxiety and behavioral comorbid 
disorders show generally earlier onset of mood disorder diagnosis and more evidence of 
psychopathology, including significantly greater ratings of mood, anxiety, and behavioral 
symptoms and an increase in substance use disorders in comparison to other groups.
PREDICTION OF MAJOR AFFECTIVE DISORDERS IN OFFSPRING
We tested the prognostic significance of childhood onset disorders in cases and controls 
(Figure 3). Two early-onset subgroups were defined to include case subjects who had a 
lifetime DSM-IV diagnosis of an anxiety disorder or an externalizing disorder (generally 
disruptive behavior disorders) with age at onset of 12 years or younger. Of those with early-
onset anxiety disorder, 9 of 25 participants (36.0%) developed a major affective disorder 
later. The RR (compared with the group without early onset of either type of disorder) after 
adjusting for comorbid anxiety/behavioral disorders in the parent/proband was 2.6 (95% CI, 
1.1–6.3; P=.04). Of those with early-onset externalizing disorder, 8 of 19 (42.1%) developed 
a major affective disorder later. The RR after adjusting for comorbid anxiety/behavioral 
disorders in the parent/proband was 3.6 (95% CI, 1.4–9.0; P=.007). Five participants had 
early onset of both anxiety and externalizing disorders (data not shown); the adjusted RR in 
this group was 6.3 (95% CI, 1.4–27.1; P=.01).
Two of 25 controls (8%) with any early-onset psychiatric disorder developed a major 
affective disorder compared with 2 of 66 controls (3%) without an early-onset disorder (P=.
25).
COMMENT
Nearly one-quarter of adolescent offspring in families with probands with BP demonstrated 
major affective disorders at an average assessment age of 17 years compared with 4% of 
controls. More than 8% of cases were diagnosed as having BPI, BPII, or BPNOS, whereas 
no control offspring received such a diagnosis. No difference was seen in any other disorder 
or group of disorders. Survival analysis showed a similar pattern, with the 2 groups 
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diverging on rate of mood disorders in childhood (at age 12 years, the risk of major affective 
disorders is 10% in cases vs 1% in controls) but not in the onset of other disorders. Most of 
the excess risk in cases is for nonbipolar major depressive disorders (either recurrent or 
single episode). The onset of minor affective disorders is not elevated in cases, although 
case subjects with minor affective disorders show an excess of comorbid externalizing 
disorders compared with other cases and deserve careful follow-up.
It is important to underscore the fact that most offspring in families with probands with BP 
will not develop BP themselves. Bipolar disorder is present in 1% to 2% of the population 
and perhaps up to 4% if BPNOS is included.36 Many of these disorders will have onset in 
adolescence (in the National Institute of Mental Health Genetics Initiative BPI sample of 
probands with BPI and affected relatives, 45% had their first onset of major mood disorder 
between ages 12 and 21 years; see the study by Dick et al37 for ascertainment and 
assessment methods), but few of these subjects with BPI had prepubertal onset of major 
mood disorder (approximately 5%–10%). See also the study by Merikangas et al38 for 
comparable results using epidemiologic methods. Most prepubertal mood episodes will be 
depressions, not manias. The median age at onset of depression for 858 subjects in the 
National Institute of Mental Health Genetics Initiative sample was 18.9 years, and the 
median age at onset of mania was 22.0 years (n=576). Approximately 12% of first episodes 
of major depression in this group were seen at 12 years or younger; approximately 5% of 
first episodes of mania were seen in that age range. On the basis of these data, we predict a 
population prevalence of 0.05% for prepubertal mania. In a report from the Systematic 
Treatment Enhancement Program for Bipolar Disorder,39 72 of 983 patients with BP had 
onset of mania at 13 years or younger, leading to an estimated population prevalence of 
0.05% to 0.1%. We suggest that substantially higher estimates may be targeting a different 
disorder (such as the syndrome of severe mood dysregulation described by Leibenluft et 
al40,41). In the present study, 3 of 141 case subjects (2.1%) and 0 of 91 controls reported 
mania during childhood years. Affectively ill case subjects in this study tended to be 
episodically rather than chronically ill.
We did not find an increase in disruptive behavior disorders in offspring at risk for BP 
compared with controls, in contrast to some previous studies.42 This may be an issue of 
sample size, as a nonsignificant increase was seen. We did see increased disruptive behavior 
disorder (without including substance use disorders) in case offspring with mood disorders 
(adjusted P=.005; RR=4.8; 95% CI, 1.6–14.0), and we did find disruptive behavior disorders 
(without substance use disorders) to be predictive of later mood disorder in cases (adjusted 
P=.03; RR=3.3; 95% CI, 1.1–9.6).
Studies of offspring at risk for the development of psychiatric disorders can support 2 types 
of comparisons: (1) cases (at higher risk) and controls (at lower risk) and (2) cases who have 
become affected and cases who have not become affected. Most offspring in families with 
probands with BP will not develop major affective disorders themselves, and so they form a 
well-matched control group for those who do. However, some well offspring have not 
passed the age of risk by the time of assessment, and some others may carry nonpenetrant 
vulnerability markers. Therefore, this type of comparison tends to increase false-negative 
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findings but decrease false-positive findings. Such cohorts may be useful in the examination 
of potential endophenotypes.
We hypothesized 3 syndromes related to BP (and related mood disorders): (1) pure 
affective, (2) internalizing (with comorbid anxiety disorder), and (3) externalizing (with 
comorbid substance use/behavioral problems). Factor analysis in adult subjects with BP 
supports this division (P.O.M.; W. H. Coryell, MD; J. Harezlak; G. A. Marcoulides, PhD; H. 
L., and C. M. Steeger; unpublished data; 2011). On this basis, we assessed severity ratings 
of mood, anxiety, and behavioral symptoms. When at-risk subjects as a group are compared 
with controls, only mood ratings differentiate the groups. But when we subdivide the at-risk 
subjects into those who are affected and those who are unaffected, differences in severity 
ratings of anxiety and behavioral symptoms become evident. Anxiety and behavioral 
symptoms and diagnoses may then be further examined as clinical predictors of major mood 
disorders.
The results of the present study suggest that nonaffective childhood psychiatric diagnoses 
may have different significance in offspring in families with BP than they do in controls 
(although they are not increased in prevalence). In at-risk offspring, these disorders seem to 
be markers of vulnerability to later onset of major mood disorders (either BP or unipolar 
disorder). Specifically, childhood anxiety disorders are associated with a 3-fold increased 
risk of major affective disorders, and childhood externalizing disorders are associated with a 
4-fold increased risk. Once a major affective disorder has begun, these data suggest that the 
course is likely to be more severe (although not necessarily BP) in subjects at familial risk. 
These observations have potential clinical significance. They reinforce the importance of 
family history in evaluating the meaning of diagnoses in children and adolescents, and they 
support a different monitoring and management strategy for children and adolescents with a 
positive family history of BP.
We should acknowledge the limitations of the present observations. The sampling methods 
are not epidemiologic, and, thus, the results may not accurately reflect population 
prevalences. The assessment of childhood diagnoses rests on a combination of retrospective 
data from child and parental observations and point-in-time data from medical records. As 
this study progresses, we intend to test these observations further in subjects at risk 
examined prospectively. We also anticipate that enrollment of larger numbers of participants 
will enable us to test hypotheses regarding the predictive significance of specific types of 
anxiety or behavioral disorders. Larger numbers should also support the differentiation of 
precursors of BP from precursors of major depression.
In the present series, African Americans are underrepresented in cases and overrepresented 
(relative to the population at the sites) in controls. We have planned a group-matching 
procedure for the study sample as it progresses and will preferentially recruit appropriate 
subjects to equalize the samples.
As an ancillary contribution of this study, we developed a modified assessment tool, the K-
SADS-BP, which conforms to DSM-IV adult criteria for BP and other Axis I diagnoses. We 
believe that this offers advantages over other versions of the K-SADS in episode definition, 
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course of illness, and direct mapping of responses onto diagnostic criteria; the computerized 
version also offers efficiency in administration and data entry. The K-SADS-BP gives 
reliable results for multiple Axis I diagnoses (see previously herein).
In summary, we described the initial stages of an ongoing longitudinal study of subjects at 
risk for BP and related disorders. A specific increase in mood disorders was seen in case 
subjects compared with controls. Affected cases tended to have more severe and impairing 
disorders than did controls. Among case subjects who have become affected, diagnoses of 
anxiety and behavioral disorders were increased, as were consensus ratings of symptoms in 
those domains. Childhood diagnoses of anxiety and externalizing disorders seemed to have 
premonitory significance in offspring in families with probands with BP in that they 
presaged adolescent development of major affective disorders. Similar findings were 
recently reported by Duffy et al.17
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Figure 1. 
Onset of major affective disorders in cases (n=141) and controls (n=91). The 2 groups are 
significantly different by log-rank test (P<.001).
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Figure 2. 
Onset of anxiety disorders (A) and externalizing disorders (B) in cases with major affective 
disorders (n=33), minor affective disorders (n=21), and no affective disorder (n=87). The 3 
groups are significantly different by log-rank test (P<.001).
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Figure 3. 
Onset of major affective disorders in cases with an externalizing diagnosis by 12 years of 
age (n=19), an anxiety diagnosis by 12 years of age (n=25), and neither early-onset 
behavioral nor anxiety disorders (n=97). The 3 groups are significantly different by log-rank 
test (P=.007).
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Table 1
Demographic and Clinical Comparison of Cases and Controls
Characteristic
Cases
(n = 141)
Controls
(n = 91) P Value Statistic
Male sex, % 48.2 52.7 .59 Exact
Age, mean (SD), y 16.7 (3.3) 16.0 (3.1) .11 t = 1.61
Ethnicity, European American, % 89.4 65.9 <.001 Exact
Education, mean (SD), last year completed 10.6 (2.5) 10.1 (2.3) .13 t = 1.51
Living with mother, % 87.2 93.0 .25 Exact
Living with father, % 66.7 65.3 .87 Exact
Telephone interview, % 66.9 61.5 .48 Exact
Proband occupation, mean (SD)a   2.6 (0.8)   2.5 (0.9) .09 W = 4346.5
Proband with anxiety disorder, %b 50.8 18.1 <.001 Exact
Proband with behavioral disorder, % 77.7 27.6 <.001 Exact
Proband without anxiety or behavioral disorder, % 14.9 60.0 <.001 Exact
Abbreviations: Exact, Fisher exact test; W, Wilcoxon rank-sum test
aScores used for head of household’s occupation were as follows: 1, executive, administrative, and managerial occupations; 2, professional 
specialty, writers, artists, entertainers, and athletes; 3, technicians, sales, administrative, private household, protective service, service, farm 
operators and managers and other farming, forestry, and fishing occupations; 4, mechanics and repairers, construction trades, extractive 
occupations, precision production occupations, machine operators, assemblers, and inspectors; and 5, other occupations, including transportation 
and material moving, handlers, equipment cleaners, helpers, and laborers.
b
Best-estimate diagnoses in case parents/probands with bipolar disorder (n = 91); Diagnostic Interview for Genetic Studies diagnoses in control 
parents (n = 105); minor mood disorders are combined with anxiety disorders in control parents.
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Table 3
Clinical Characteristics of Affective Episodes in Cases and Controls
Characteristic
Cases
(n = 54)
Controls
(n = 17) P Value Statistic
Major affective disorders, No. (%)        33 (61.1)        4 (23.5) .01 Exact
Minor affective disorders, No. (%)        21 (38.9)      13 (76.5)
Age at onset of mania, median (IQR), y     12.5 (10–14)        NA NA NA
Age at onset of depression, median (IQR), y        12 (10.5–15.5)   13.5 (12–14) .53 W = 90
Age at onset of hypomania, median (IQR), y        16 (11.5–17.0)        NA NA NA
Multiple episodes (any polarity), No. (%)        20 (37.0)        1 (5.9) .02 Exact
Clear episodic disorder, No. (%)a        16 (29.6)        2 (11.8) >.99  Exact
Persistent affective symptoms, No. (%)a        10 (18.5)        1 (5.9)
Any psychotic symptoms, No. (%)          8 (14.8)        0 .18 Exact
Mixed episodes (possible or definite), No. (%)
   8/49b (16.3)        0 .12 W
Rapid cycling (definite), No. (%)          1 (1.9)
       0/16b >.99  Exact
Suicidal thoughts or behavior, No. (%) 23/53b (43.4)        7 (41.2) .67 W
Comorbid substance abuse, No. (%) 16/49b (32.7) 3/12b (25.0) .71 W
Episode severity moderate or greater, No. (%) 38/51b (74.5) 8/16b (50.0) .08 W
Significant effect on life functioning, No. (%) 22/50b (44.0)        2 (11.8) .02 Exact
Abbreviations: Exact, Fisher exact test; IQR, interquartile range; NA, not applicable; W, Wilcoxon rank-sum test.
aComparisons are among subjects with illness of 2 years or more (26 cases and 3 controls) because those with illness of less than 2 years would be 
indeterminate for these variables.
bWhere denominators are reduced by missing data, this is noted by inclusion of the true denominator.
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